Covenant Multifamily Offices’s AbbVie ABBV Stock Holding History

Covenant Multifamily Offices’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$3.3M	Sell	30,152 -1,121	-4%	-$128K	0.59%	25
2021 Q2	$3.52M	Sell	31,273 -5,336	-15%	-$601K	0.64%	23
2021 Q1	$3.96M	Buy	36,609 +223	+0.6%	+$23.9K	0.81%	17
2020 Q4	$3.9M	Buy	36,386 +230	+0.6%	+$22.1K	0.7%	13
2020 Q3	$3.17M	Sell	36,156 -2,514	-7%	-$237K	0.62%	19
2020 Q2	$3.8M	Sell	38,670 -2,868	-7%	-$253K	0.75%	14
2020 Q1	$3.17M	Sell	41,538 -11,187	-21%	-$953K	0.8%	13
2019 Q4	$3.35M	Buy	52,725 +30,571	+138%	+$2.54M	0.57%	24
2019 Q3	$1.68M	Buy	22,154 +1,982	+10%	+$136K	0.36%	35
2019 Q2	$1.47M	Buy	+20,172	New	+$1.59M	0.32%	44

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Covenant Multifamily Offices's ABBV Position: Q3 2021 in Review

Covenant Multifamily Offices reduced its AbbVie (ABBV) stake by 3.6% in Q3 2021, selling an estimated $128K and leaving 30,152 shares worth $3.3M. The position accounts for 0.59% of the portfolio, ranked #25.

Covenant Multifamily Offices first reported a position in ABBV in Q2 2019 and has held it in 10 quarters since. The position peaked at $3.96M in Q1 2021. 2,655 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

Covenant Multifamily Offices held 30,152 shares of AbbVie worth $3.3M as of Q3 2021.
Covenant Multifamily Offices sold 1,121 AbbVie shares in Q3 2021, an estimated $128K.
AbbVie made up 0.59% of Covenant Multifamily Offices's portfolio in Q3 2021, its #25 holding.
Covenant Multifamily Offices first reported a position in AbbVie in Q2 2019 and has held it in 10 quarters since.
Covenant Multifamily Offices's AbbVie position peaked at $3.96M in Q1 2021.
2,655 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Covenant Multifamily Offices's 13F filing for Q3 2021, filed 21 Oct 2021.